| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 111,683 | 108,374 | 96,292 | 105,835 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 108,374 | 96,292 | 105,835 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 101,998 | 58,298 | 67,130 | 83,782 | | Non Recurring | (9,710) | 19,438 |
-
|
-
| | Others | 22,427 | 21,522 | 22,011 | 23,208 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 6,021 | 9,116 | 7,152 | (1,156) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 6,696 | 9,116 | 7,152 | (1,156) | | Interest Expense | 225 | 225 | 225 | 225 | | Income Before Tax | 6,471 | 8,891 | 6,927 | (1,381) | | Income Tax Expense | 1,420 | 1,924 | 1,123 | (1,854) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 5,051 | 6,967 | 5,804 | 474 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,051 | 6,967 | 5,804 | 474 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,051 | $6,967 | $5,804 | $474 |
|
0.03% Nasdaq 
Income Statement
